Europe — EMA
Oridopa (Carbidopa, Levodopa)
Carbidopa, the active ingredient in Oridopa, the active ingredient in Oridopa, is a dopamine‑rehydroxylase inhibitor presented as a combination tablet for oral use.
Request sourcing
What is Carbidopa, Levodopa?
Carbidopa, the active ingredient in Oridopa, the active ingredient in Oridopa, is a dopamine‑rehydroxylase inhibitor presented as a combination tablet for oral use. It treats Parkinson's disease and related movement disorders in adults. GNH USA supplies Oridopa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Oridopa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Carbidopa, Levodopa used for?
Oridopa is a combination therapy that targets the dopaminergic pathway in Parkinsonian disorders.
- Parkinson's disease: improves motor symptoms such as tremor, rigidity and bradykinesia. - Restless‑type dyskinesia: reduces involuntary movements associated with long‑term levodopa therapy. - Parkinsonian syndrome after stroke or traumatic brain injury: helps restore dopaminergic tone. - Drug induced tension or tension t t t t.
What are the side effects of Carbidopa, Levodopa?
The ... ... ...
